agilon health inc
NYSE:AGL
agilon health inc
NYSE:AGL
Price:
5.21 USD
-2.43%
Updated:
Apr 24, 2024
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to FCFF
-9.2
Current
-44.8
Median
19.3
Industry
Higher
than median
Lower
than industry value
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
EV/FCFF
=-9.2
Enterprise Value
/
1.7B
FCFF
-187m
All Countries
| Market Cap | EV/FCFF | ||||
|---|---|---|---|---|---|
| US |
|
agilon health inc
NYSE:AGL
|
2.2B USD | -9.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.4B EUR | 12.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
103B USD | 12.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
87.4B USD | 13 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.4B USD | 24 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.4B EUR | 8.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 21.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.4B EUR | 10.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
11.8B USD | 13.2 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -25.2 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A
You don't have any saved screeners yet
